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Abstract 
Hydroxyapatite nanopowders were prepared in the presence of different concentrations of 
zirconium ions. Such crystallization conditions yielded significantly reduced particle size and 
increased specific surface area. Cell viability and oxidative stress studies showed that 
biocompatibility was not impaired when compared to pure hydroxyapatite. Non-isothermal 
sintering implied the possibility for suppressing the reaction between hydroxyapatite and zirconia 
by limiting it to only calcium phosphates. Stress-induced transformation of tetragonal to 
monoclinic is facilitated by total hydroxyapatite to β-tricalcium phosphate phase transformation.  
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Introduction 
The improvement of material properties without negatively affecting the biological response is a 
permanently targeted issue concerning bioceramics. Hydroxyapatite (HAp) is a bioactive material 
and one of the most suitable ceramics for bone and dental tissue reconstruction, but still lacks 
adequate mechanical properties. However, zirconia (ZrO2) offers good mechanical response, but 
has a disadvantage of poor bonding to host tissue. Their composites are quite promising, though, 
offering many potential biological and structural advantages. HAp/ZrO2 composites are usually 
prepared by physical mixing or colloidal dispersions of ZrO2 with HAp [1]. The addition of other 
phases to HAp influences its bioactivity and phase stability during sintering [2]. Procedures that 
reduce the amount of reinforcing agents have already been investigated [3]. Also, pressureless 
densification of HAp/ZrO2 is difficult because of the mismatch in thermal expansion coefficients 
and requires field-assisted sintering techniques and tetragonal ZrO2 (t-ZrO2) stabilization since 
there is a tendency to reactions between HAp and ZrO2 [4,5].  
 In this study, the preparation of HAp nanopowders in the presence of different amounts 
of zirconium ions was performed under reflux conditions. Detailed structural and chemical 
characterizations were performed, while biocompatibility was determined in cytotoxicity and 
oxidative stress studies. Non-isothermal sintering was performed up to 1300 °C and the results 
were correlated with the phase composition. 
 
Materials and methods 
Chemical precipitation has been performed with following precursors: calcium nitrate 
tetrahydrate, Ca(NO3)2·4H2O, (Fluka Analytical, Germany), zyrconyl chloride octahydrate, 
ZrOCl2·8H2O, (The British Drug Houses Ltd., United Kingdom) and ammonium dihydrogen 
phosphate, NH4H2PO4, (Zorka Šabac, Serbia). Concentrations were adjusted to retain (Ca+Zr)/P 
molar ratio of 1.67 for different amounts of zirconium (0, 1, 5 and 10 at.% with respect to Ca), 
denoted as HAp-X (X= 0, 1, 5, 10), respectively. Reactants were dissolved in 80 ml of distilled 
water each and heated to 70 °C. The solutions of calcium and zirconium ions were mixed, 
followed by the addition of a phosphate solution and precipitation by the dropwise addition of 10 
ml of NH4OH to reach pH 11. The reaction batch (250 ml), enclosed in reflux conditions to 
provide constant pH in the presence of small amount of NH4OH, was effectively stirred for 3 h at 
70 °C, with afterward ageing, washing out to pH 7 and drying. The phase analysis was carried out 
using X-ray diffraction (Philips PW-1050). The FTIR measurement was performed in the spectral 
range of 400–4000 cm−1 (BOMEM, Hartmann& Braun). Particle size and morphology were 
investigated using transmission electron microscopy (TEM, JEOL 2100); elemental mapping was 
performed by EDXS analysis (JEOL ARM 200 CF equipped with JEOL centurion 100). The 
specific surface area (SSA) was measured by Brunauer–Emmett–Teller (BET) technique with N2 
adsorption–desorption isotherms at −195.8 °C (Micromeritics Gemini 2370 V5).  
 For determination of the biological response we used HepG2 cells, which were obtained 
from the European Collection of Cell Cultures (UK) and were grown as described previously [6]. 
The cytotoxicity was determined with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) according to Mosmann [7], with minor modifications [6]. The HepG2 cells were 
seeded onto 96-well microplates (Nunc, Naperville IL, USA) at a density of 40000 cells/ml and 
incubated for 20 h at 37 oC to attach. The medium was replaced by fresh medium containing 0, 
0.00001, 0.0001, 0.001, 0.01 and 0.1 % (w/v) of HAp-X (X = 0, 1, 5, 10) samples and incubated 
for 24 h. In each experiment a negative control (non-treated cells) was included. The protocol was 
continued as described previously [6]. Cell survival was determined by comparing the optical 
density of the wells containing the treated cells with those of the negative control.  
 The formation of intracellular reactive oxygen species (ROS) was measured 
spectrophotometrically using the fluorescent probe DCFH-DA [8], with minor modifications [6]. 
The HepG2 cells were seeded at a density of 75000 cells/ml into 96-well, black microplates 
(Nunc, Naperville IL, USA) in five replicates and incubated for 20 h at 37 °C to attach. After that, 
the cells were incubated with 20 mM DCFH-DA for 30 min, then DCFH-DA was removed, and 
cells were washed out with PBS and treated with concentrations 0, 0.00001, 0.0001, 0.001, 0.01 
and 0.1 % (v/v) of HAp-X (X= 0, 1, 5, 10) samples. Negative control (non-treated cells) and 
positive control (0.5 mM tert-butyl hydroperoxide treated) were always included. The protocol 
was continued as described previously [6].  
The powders were uniaxially pressed under 100 MPa. Non-isothermal sintering was 
performed to 1300 °C in a heating microscope (New Heating Microscope EM201, Hesse 
Instruments) with the heating rate of 10 °C/min. 
 
Results and discussion 
XRD patterns of the prepared materials, Fig. 1a, showed the reflections characteristic for HAp. 
The only difference among these samples was the diffuse scattering in 20-40o 2θ range for HAp-
10 sample, which could originate from ZrO2 phase [9].  
FTIR spectra, Fig. 1b, of the synthesized powders were almost identical, showing typical 
apatite phosphate (PO 34 ) modes at: 470 cm
1 (ν2 bending vibration), 564 and 602 cm1 (ν4 
bending vibration), 962 cm1 (ν1 symmetric stretching vibration), and in the 1000–1150 cm1 
region (ν3 asymmetric stretching mode). The bands at 1637 and in the 3000–3650 cm1 range are 
attributed to associated water. The O–H libration and stretching modes appeared at 632 and 3570 
cm1, respectively. Vibrational bands at 669, 875 cm1 and in the 1450–1500 cm1 region are 
attributed to ν4, ν2 and ν3 stretching modes of incorporated carbonates, respectively.  
Deconvolution of 400–750 cm-1 spectral region of HAp-5 and HAp-10 yielded three more 
peaks centered at 425, 525, and 580 cm1 that could be attributed to ZrO stretching mode [10], 
suggesting the formation of ZrO2 phase and the existence of HAp/ZrO2 composite. 
 The results of TEM analysis, shown in Fig. 2, revealed that all the prepared powders 
possessed uniform particles. However, with higher concentrations, both the particle size and their 
aspect ratio changed. The particles of HAp-0 were 150 nm long and around 20 nm wide, while 
those of HAp-10 had the length of around 45 nm and the width of less than 10 nm, with more 
rounded morphology. The EDXS analysis showed that ZrO2 is uniformly dispersed within the 
samples; slight aggregation was observed for higher initial concentrations of zirconium. The size 
of zirconia particulates is around 25 nm, with rounded morphology. Reduction of the particle size 
led to an increase of SSA, being 74, 73, 126, and 137 m2/g for HAp-X (X= 0, 1, 5, 10) samples, 
respectively.  
Biocompatibility studies of the prepared nanopowders confirmed that the initial 
properties of pure HAp were not impaired with the addition of zirconium ions. The cytotoxicity 
determined by MTT assay after 24 h exposure, Fig. 3a, revealed that all samples have 
concentration-dependent, but comparable levels of cytotoxicity, independent on the amount of 
zirconium ions. On the other side, measurements of the oxidative stress induced in Hep G2 cells, 
Fig. 3b, showed that all the samples after 5 h induced favourable response, without significant 
generation of ROS. Only the highest concentration showed the ROS increase. 
From non-isothermal sintering studies, Fig. 4a, very different sintering behavior was 
found and correlated to the phase composition, Fig. 4b. HAp-0 sample sintered around 1100 °C 
remained pure HAp phase due to stoichiometric Ca/P ratio. HAp-1 sample had a lower bulk 
density and the dominant presence of HAp phase with a small amount of β-tricalcium phosphate 
(β-TCP) phase and the appearance of t-ZrO2. The lower density is explained by densification 
suppression in the presence of TCP phases with lower theoretical densities (2.86, 3.07 and 3.16 
gcm-3 for α-TCP, β-TCP and HAp, respectively). HAp-5 showed better densification comparing 
to HAp-1. Phase composition analysis revealed a higher amount of t-ZrO2 phase in co-existence 
with HAp and α-TCP»β-TCP phases. The fact that HAp-1 and HAp-5 retained t-ZrO2 could be 
suitable for formation of BCP/ZrO2 [11]. The formation of cubic zirconia and/or calcium 
zirconate above 1200 °C [12], which could inhibit the toughening mechanism through 
transformation of t-ZrO2 to m-ZrO2, was not observed. Since HAp-1 and HAp-5 are basically Ca-
deficient HAp, they decompose above 700 °C and prevent the reaction between HAp and t-ZrO2. 
HAp-10 sample showed two distinct sintering regions: enhanced sintering up to 900 °C 
and subsequent retardation from 900 to 1100 °C. Biodegradable β-TCP appeared as the only 
calcium phosphate phase, while m-ZrO2 was the dominant phase compared to t-ZrO2. The 
explanation for such a phase composition is related to the initial Ca/P ratio of HAp-10 sample, 
being 1.5, which yields total decomposition of HAp to β-TCP; that is accompanied with sudden 
volume expansion, which could provoke stress-induced transformation of t-ZrO2 to m-ZrO2. This 
is expressed as retardation in the sintering curves, Fig. 4a. It is important to observe that HAp-10 
starts sintering at 800 °C due to Ca2+ vacancies in HAp crystal lattice. As a suggestion for the 
further research, phase transformation stresses could be avoided in water vapor atmosphere, and 
the final system could retain t-ZrO2, susceptible to transformation toughening under mechanical 
loading. 
 
Conclusions 
Hydroxyapatite nanopowders were successfully prepared in the presence of zirconium ions. With 
zirconium addition, the particle morphology became more rounded and the particle size 
significantly decreased, from 150 to 45 nm in length and from 20 to 10 nm in width, yielding the 
doubling of SSA. Biocompatibility was not altered compared to pure HAp. Sintering studies 
showed that the phase composition could be tailored by the appropriate choice of zirconium 
amount and that HAp-1 and HAp-5 samples exhibited the presence of only t-ZrO2 after non-
isothermal sintering. For HAp-10 sample, it was shown that the complete phase transformation 
from HAp to β-TCP provoked stress-induced transformation of t-ZrO2 to m-ZrO2. Using HAp 
with Ca/P ratio 1.67 ≤ x ≤ 1.5, the reaction between HAp and ZrO2 is suppressed by providing an 
alternative, less energy-consuming pathway of Ca-deficient HAp decomposition, confining the 
reaction only to the calcium phosphate phase. 
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Figure captions 
Fig. 1 a) XRD patterns and b) FTIR spectra of precipitated powders. 
Fig. 2 TEM micrographs of prepared nanopowders; EDXS mapping of Zr density, and Ca and Zr 
concentration.  
Fig. 3 a) MTT assay and b) ROS study of prepared nanopowders. 
Fig. 4 a) Non-isothermal sintering curves to 1300 °C and b) corresponding XRD patterns.  
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